Great Valley Advisor Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,341	Closed	-$1.01M	–	520
2020 Q4	$1.01M	Buy	+16,341	New	+$1.01M	0.1%	181